Cost-effectiveness of tenofovir gel in urban South Africa: model projections of HIV impact and threshold product prices
January 2014
Click for full info +Cost-effectiveness of tenofovir gel in urban South Africa: model projections of HIV impact and threshold product prices
 | 09 January 2014 |
In this Journal Article:
Health Risk(s):HIV
Product Type(s):Microbicides
Topic(s):Product Development
Full Info:
Resource Type:
Citation:
Terris-Prestholt, F., Foss, A. M., Cox, A. P., Heise, L., Meyer-Rath, G., Delany-Moretlwe, S., … & Watts, C. H. (2014, January 9). BMC infectious diseases, 14(1), 14.
Authors:
Terris-Prestholt, F., Foss, A. M., Cox, A. P., Heise, L., Meyer-Rath, G., Delany-Moretlwe, S., ... & Watts, C. H.
Health Risks(s):
- HIV
Product type(s):
- Microbicide
Topic(s):
- Development
URL of resource: